phe885
novartis
['phe885']
phe885 car t (fast t-charge manufacturing) provides 100% overall response with a 10 day or less turn around time in ph1 study of 49 patients. #asco23 
Multiple Myeloma Research Foundation - Accelerating the development of next generation #myeloma treatments to extend patient’s lives, and lead to a cure.